Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Sherr

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Journal of the American Society of Nephrology : JASN|May 29, 2015
The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in UremiaSowmya Shivanna, Kumaran Kolandaivelu, Moshe Shashar, et al.
Stem Cells (Dayton, Ohio)|March 24, 2018
Notch and Aryl Hydrocarbon Receptor Signaling Impact Definitive Hematopoiesis from Human Pluripotent Stem CellsAmy Leung, Elizabeth Zulick, Nicholas Skvir, et al.
Molecular Neurodegeneration|May 7, 2017
Dioxins and related environmental contaminants increase TDP-43 levelsPeter E A Ash, Elizabeth A Stanford, Ali Al Abdulatif, et al.
Molecular Pharmacology|August 31, 2016
An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer CellsOlga Novikov, Zhongyan Wang, Elizabeth A Stanford, et al.
Toxicologic Pathology|November 3, 2005
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumorsNicolas Currier, Sandra E Solomon, Elizabeth G Demicco, et al.
Plos One|February 6, 2014
Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 productionMargaret M Lowe, Jeff E Mold, Bittoo Kanwar, et al.
Molecular Pharmacology|August 28, 2014
In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivoAshley J Parks, Michael P Pollastri, Mark E Hahn, et al.
Blood|July 19, 2003
The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cellsBritta Maecker, David H Sherr, Robert H Vonderheide, et al.
Science Translational Medicine|November 24, 2017
Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding riskMoshe Shashar, Mostafa E Belghasem, Shinobu Matsuura, et al.
Blood|June 1, 2013
The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiationBrenden W Smith, Sarah S Rozelle, Amy Leung, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Journal of the American Society of Nephrology : JASN|May 29, 2015
The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in UremiaSowmya Shivanna, Kumaran Kolandaivelu, Moshe Shashar, et al.
Stem Cells (Dayton, Ohio)|March 24, 2018
Notch and Aryl Hydrocarbon Receptor Signaling Impact Definitive Hematopoiesis from Human Pluripotent Stem CellsAmy Leung, Elizabeth Zulick, Nicholas Skvir, et al.
Molecular Neurodegeneration|May 7, 2017
Dioxins and related environmental contaminants increase TDP-43 levelsPeter E A Ash, Elizabeth A Stanford, Ali Al Abdulatif, et al.
Molecular Pharmacology|August 31, 2016
An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer CellsOlga Novikov, Zhongyan Wang, Elizabeth A Stanford, et al.
Toxicologic Pathology|November 3, 2005
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumorsNicolas Currier, Sandra E Solomon, Elizabeth G Demicco, et al.
Plos One|February 6, 2014
Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 productionMargaret M Lowe, Jeff E Mold, Bittoo Kanwar, et al.
Molecular Pharmacology|August 28, 2014
In silico identification of an aryl hydrocarbon receptor antagonist with biological activity in vitro and in vivoAshley J Parks, Michael P Pollastri, Mark E Hahn, et al.
Blood|July 19, 2003
The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cellsBritta Maecker, David H Sherr, Robert H Vonderheide, et al.
Science Translational Medicine|November 24, 2017
Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding riskMoshe Shashar, Mostafa E Belghasem, Shinobu Matsuura, et al.
Blood|June 1, 2013
The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiationBrenden W Smith, Sarah S Rozelle, Amy Leung, et al.
Pageof 8